T16	Effect 205 243	risk of arterial or venous thrombosis.
T17	Treatment 0 28	Porcine factor VIII (pFVIII)
T18	Subject 67 174	patients with congenital or acquired haemophilia who have high-titre neutralizing antibodies to human FVIII
T21	Treat-Disorder 125 174	high-titre neutralizing antibodies to human FVIII
T23	Speculation_cue 205 209	risk
T24	Drug 0 19	Porcine factor VIII
T22	Negation_cue 179 182	not
T28	Treat-Disorder 55 63	bleeding
T19	Treat-Disorder 81 115	congenital or acquired haemophilia
T15	Adverse_event 192 200	increase
E1	Adverse_event:T15 
